Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Gemphire Therapeutics Inc (GEMP)

8.17 0.25 (3.16%)

01-19 16:00

Open:

7.9

Pre. Close:

7.92

High:

8.55

Low:

7.8

Volume:

53,494

Market Cap:

87M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.56 - 8.593

8.593 - 8.626

Low:

7.719 - 7.756

7.756 - 7.793

Close:

8.108 - 8.167

8.167 - 8.225

Technical analysis  (as of: 2018-01-19 4:24:34 PM)

Overall:

      

Stoxline posted a STRONG BUY today, same as yesterday. This stock still seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 9.99     One year: 11.66

Support:

Support1: 7.35    Support2: 6.61

Resistance:

Resistance1: 8.55    Resistance2: 9.99

Pivot:

7.74

Moving Averages:

MA(5): 7.57     MA(20): 7.80

MA(100): 9.00     MA(250): 10.44

MACD:

MACD(12,26): -0.18     Signal(12,26,9): -0.24

%K %D:

%K(14,3): 64.10     %D(3): 45.34

RSI:

RSI(14): 53.79

52-Week:

High: 21.59  Low: 6.61  Change(%): -22.3

Average Vol(K):

3-Month: 3523  10-Days 4962

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
GEMP has closed below upper band by 18.4%. Bollinger Bands are 12.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 06 Sep 2017 13:07:30 GMT
Gemphire Therapeutics: Our Take On This ~$10 Biotech Concern

Mon, 20 Jun 2016 17:19:59 GMT
Gemphire Therapeutics sets IPO for Thursday

Fri, 24 Jun 2016 14:16:50 GMT
Gemphire Therapeutics delays IPO over uncertainty caused by Brexit

Sun, 21 Jan 2018 15:33:45 GMT
Decision Time: Gemphire Therapeutics Inc (NASDAQ:GEMP) Stock Technicals Hit ...

Fri, 10 Mar 2017 17:03:45 GMT
Gemphire Therapeutics to sell $12.5 million in stock

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

10.63

Shares Float (M)

4.27

% Held by Insiders

46.24

% Held by Institutions

30.94

Shares Short (K)

577

Shares Short Prior Month (K)

561

Stock Financials

EPS

-3.400

EPS Est. Current Year

-2.980

EPS Est. Next Year

-2.620

EPS Est. Next Quarter

-0.590

Forward EPS

-2.735

Book Value (p.s.)

0.940

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-70.7

Return on Equity (ttm)

-183.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-23.76

Levered Free Cash Flow (M)

-9.71

atoplab.com

Valuation

P/E

-2.40

P/E Growth Ratio

0.03

P/BV

8.69

P/S

P/CF

-3.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.